Kiri

Saatja: EVD.Outbreak <[email protected]>
Saatmisaeg: esmaspäev, 27. mai 2024 16:17
Adressaat: mateusz.markowicz <[email protected]>; stephan.aberle <[email protected]>; El-Khatib Ziad <[email protected]>; irene.kaszoni-rueckerl <[email protected]>; lena.koenig <[email protected]>; Benka Bernhard <[email protected]>; tinne.lernout <[email protected]>; Javiera Rebolledo <[email protected]>; dominique.vanbeckhoven <[email protected]>; jessika.deblonde <[email protected]>; Ruben Brondeel <[email protected]>; yves.dupont <[email protected]>; elica.panayotova <[email protected]>; iva_trrifonova <[email protected]>; mikov <[email protected]>; mtyufekchieva <[email protected]>; nvladimirova <[email protected]>; Nikolay Bogdanov <[email protected]>; tonyminkova <[email protected]>; zvjezdana.lovric <[email protected]>; iva.pem-novosel <[email protected]>; tatjana.nemeth-blazic <[email protected]>; Mirjana Lana Kosanović Ličina <[email protected]>; sanja.kurecicfilipovic <[email protected]>; maja.ilic <[email protected]>; aaristodimou <[email protected]>; Valentinos Silvestros <[email protected]>; m.mendris <[email protected]>; mviolaris <[email protected]>; drelenax <[email protected]>; georgiossiakallis <[email protected]>; Fani Theophanous <[email protected]>; Christiana Stavraki <[email protected]>; Christopher Haralambous <[email protected]>; Valentinos Silvestros <[email protected]>; Hana Orlíková <[email protected]>; hana.zelena <[email protected]>; hana.zakoucka <[email protected]>; Jan Kynčl <[email protected]>; Lasse Skafte Vestergaard <[email protected]>; pvb <[email protected]>; Anders Koch <[email protected]>; Maria Wessman <[email protected]>; Sidsel Skou Voss <[email protected]>; Tyra Grove Krause <[email protected]>; Maria Vikentjeva <[email protected]>; Jelena Rjabinina <[email protected]>; Hanna Maria Aavik <[email protected]>; kristi.ruutel <[email protected]>; Jevgenia Epštein <[email protected]>; pamela.osterlund <[email protected]>; Liina Voutilainen <[email protected]>; Henrikki Brummer-Korvenkontio <[email protected]>; Kirsi Liitsola <[email protected]>; Tuula Hannila-Handelberg <[email protected]>; Tuija Leino <[email protected]>; Marie-Claire PATY <[email protected]>; Henriette de Valk <[email protected]>; KUNKEL Amber <[email protected]>; Florence LOT <[email protected]>; Harold NOEL <[email protected]>; frankc <[email protected]>; WilkingH <[email protected]>; bremerv <[email protected]>; BenzlerJ <[email protected]>; dierckem <[email protected]>; Danai Pervanidou <[email protected]>; Georgia Nikolopoulou <[email protected]>; Ioanna Magaziotou <[email protected]>; k.gkolfinopoulou <[email protected]>; Kassiani Mellou <[email protected]>; molnar.zsuzsanna <[email protected]>; nagy.orsolya <[email protected]>; kozma.emese <[email protected]>; molnar.zsuzsanna <[email protected]>; hajdu.agnes <[email protected]>; molnar.zsuzsanna <[email protected]>; Anna Margrét Guðmundsdóttir - Landl <[email protected]>; Kamilla Sigríður Jósefsdóttir - Landl <[email protected]>; Guðrún Aspelund - Landl <[email protected]>; Anna Margrét Guðmundsdóttir - Landl <[email protected]>; Erna Milunka Kojic <[email protected]>; Maríanna Þórðardóttir - Landl <[email protected]>; Guðrún Aspelund - Landl <[email protected]>; Anna Margrét Guðmundsdóttir - Landl <[email protected]>; Paul.McKeown <[email protected]>; patricia.garvey <[email protected]>; aoife.colgan <[email protected]>; Niamh.Murphy <[email protected]>; Kate ODonnell <[email protected]>; [email protected]; derval.igoe <[email protected]>; Greg Martin <[email protected]>; Louise Cullen <[email protected]>; patricia.garvey <[email protected]>; Lisa.Domegan <[email protected]>; Riccardo Flavia <[email protected]>; Federica Ferraro <[email protected]>; Suligoi Barbara <[email protected]>; mariaelena.tosti <[email protected]>; Francesco Maraglino <[email protected]>; Bonfigli Sandro <[email protected]>; Antra Bormane <[email protected]>; Jurijs Perevoščikovs <[email protected]>; Walser-Domjan Esther <[email protected]>; Walser-Domjan Esther <[email protected]>; Walser-Domjan Esther <[email protected]>; algirdas.griskevicius <[email protected]>; Galina Zagrebnevienė <[email protected]>; milda.zygutiene <[email protected]>; vilnele.lipnickiene <[email protected]>; giedre.aleksiene <[email protected]>; Jurgita Pakalniškienė <[email protected]>; giedre.aleksiene <[email protected]>; Rasa Liausedienė <[email protected]>; Patrick HOFFMANN <[email protected]>; Joël Mossong <[email protected]>; Jean-Claude Schmit <[email protected]>; Melillo Tanya at Health Regulation <[email protected]>; Borg Maria-Louise at Health Regulation <[email protected]>; Melillo Jackie M at Health Regulation <[email protected]>; Melillo Tanya at Health Regulation <[email protected]>; Gauci Charmaine at Health Regulation <[email protected]>; Melillo Tanya at Health Regulation <[email protected]>; Chantal Reusken <[email protected]>; Eelco Franz <[email protected]>; Birgit van Benthem <[email protected]>; Eline Op de Coul <[email protected]>; Gijs Klous <[email protected]>; Loes Soetens <[email protected]>; Elisabeth Astrup <[email protected]>; Johansen, Tone Kristin Bjordal <[email protected]>; hilde.klovstad <[email protected]>; Kathrine Stene-Johansen <[email protected]>; hilde.klovstad <[email protected]>; Løvlie, Astrid Louise <[email protected]>; Sadkowska-Todys Małgorzata <[email protected]>; Niedźwiedzka-Stadnik Marta <[email protected]>; Sadkowska-Todys Małgorzata <[email protected]>; Rosińska Magdalena <[email protected]>; Paula Vasconcelos <[email protected]>; João Vieira Martins <[email protected]>; Rui Tato Marinho <[email protected]>; Vitor Verissimo <[email protected]>; mjalbuquerque <[email protected]>; Pedro Licinio Pinto Leite <[email protected]>; Anca Sirbu <[email protected]>; [email protected]; Mariana Mardarescu <[email protected]>; Anca Sirbu <[email protected]>; Adriana Pistol <[email protected]>; jana.kerlik <[email protected]>; edita.staronova <[email protected]>; Bražinová Alexandra <[email protected]>; eva.chmelanova <[email protected]>; Danica Staneková <[email protected]>; Mária Avdičová <[email protected]>; jan.mikas <[email protected]>; maja.socan <[email protected]>; eva.grilc <[email protected]>; tanja.kustec <[email protected]>; Irena Klavs <[email protected]>; eva.grilc <[email protected]>; veronika.ucakar <[email protected]>; Sierra Moros. María José <[email protected]>; Paz Sánchez-Seco <[email protected]>; jamo <[email protected]>; Asunción Díaz Franco <[email protected]>; mvarelam <[email protected]>; anette.richardson <[email protected]>; [email protected]; maria.axelsson <[email protected]>; lena.dillner <[email protected]>; anneli.carlander <[email protected]>; [email protected]; anneli.carlander <[email protected]>; Anders Lindblom <[email protected]>; anders.wallensten <[email protected]>
Koopia: NC_CCB_Austria <[email protected]>; sigrid.kiermayr <[email protected]>; koen.blot <[email protected]>; [email protected]; Zhivka Getsova <[email protected]>; Iva Christova <[email protected]>; kcapak <[email protected]>; bernard.kaic <[email protected]>; Elisavet Constantinou <[email protected]>; [email protected]; Hana Orlíková <[email protected]>; Kamilla Grønborg Laut <[email protected]>; Stine Ulendorf Jacobsen <[email protected]>; Kärt Sõber <[email protected]>; TA Info <[email protected]>; Otto Helve <[email protected]>; Savolainen-Kopra Carita <[email protected]>; Paula GARCIA-LOBATO <[email protected]>; Anne-Catherine VISO <[email protected]>; [email protected]; Rexroth, Ute <[email protected]>; AnderHeidenMa <[email protected]>; Theodora Kalomama <[email protected]>; Dimitrios Paraskevis <[email protected]>; Christakis Chatzichristodoulou <[email protected]>; [email protected]; phc.office <[email protected]>; Rezsőfi Judit <[email protected]>; Guðrún Aspelund - Landl <[email protected]>; Greg Martin <[email protected]>; Kate Loughnane <[email protected]>; patricia.garvey <[email protected]>; Louise Cullen <[email protected]>; Lisa.Domegan <[email protected]>; Aine Grace <[email protected]>; Francesco Maraglino <[email protected]>; Antra Bormane <[email protected]>; Dehler Silvia, Dr. med. <[email protected]>; Jurgita Pakalniškienė <[email protected]>; greta.gargasiene <[email protected]>; Jurgita Pakalniškienė <[email protected]>; Jean-Claude Schmit <[email protected]>; Gauci Charmaine at Health Regulation <[email protected]>; Hester.de.Melker <[email protected]>; Susan van den Hof <[email protected]>; Macdonald, Emily Ann <[email protected]>; Heidi Lange <[email protected]>; Zacharczuk Katarzyna <[email protected]>; Mariana Ferreira <[email protected]>; Pedro Licinio Pinto Leite <[email protected]>; [email protected]; André Peralta Santos <[email protected]>; Adriana Pistol <[email protected]>; ecdc <[email protected]>; jan.mikas <[email protected]>; [email protected]; Marta.vitek <[email protected]>; Fernando Simón Soria <[email protected]>; [email protected]; [email protected]; Agneta Falk Filipsson <[email protected]>; Sara Bengtsson <[email protected]>; birgitta.lesko <[email protected]>; anette.richardson <[email protected]>; episurveillance <[email protected]>; EVD.Outbreak <[email protected]>; Celine Gossner <[email protected]>; Xanthi Andrianou <[email protected]>; Mohammed Afzal <[email protected]>; ECDC Info <[email protected]>
Teema: For action: monthly reporting of mpox cases through TESSy in 2024

To: National Focal Point for Emerging and vector-borne diseases; National Focal Point for HIV/AIDS, STI and hepatitis B/C; National Focal Point for Surveillance

CC: National Coordinator

Dear colleagues,

As the end of the year approaches, we would like to inform you of the reporting schedule for early 2024.  The next deadlines for reporting in 2024 will be at 10:00 AM on the following dates:

• 11 January 2024

• 8 February 2024

• 7 March 2024

• 4 April 2024

• 2 May 2024

The monthly reported data will contribute to the production of a now quarterly ECDC/WHO EURO joint bulletin (next published on 12 January 2024) as well as the monthly reporting to WHO Headquarters and associated outputs.

In the case of any unexpected increase in case numbers or presence of cases in specific risk groups, we kindly request that you please report these through event-based surveillance mechanisms (EpiPulse/EWRS/IHR routes). 

If you have any questions or require further information, please do not hesitate to contact us at [email protected] (ECDC) or [email protected] (WHO Europe).

We would like to take this opportunity to wish you a restful break over the holidays, and a happy and healthy New Year.

Best wishes,

ECDC and WHO EURO mpox teams

To: National Focal Point for Emerging and vector-borne diseases; National Focal Point for HIV/AIDS, STI and hepatitis B/C; National Focal Point for Surveillance

CC: National Coordinator

Dear Colleagues,

As previously informed, mpox reporting to TESSy will be kept on a monthly basis. The next deadlines for reporting in 2023 will be November 9, 2023, by 10:00 AM and December 7, 2023, by 10:00 AM.

The monthly reported data will contribute to the production of a now quarterly ECDC/WHO EURO joint bulletin as well as the monthly reporting to WHO Headquarters and associated outputs.

In the case of any unexpected increase in case numbers or presence of cases in specific risk groups, we kindly request that you please report these through event-based surveillance mechanisms (EpiPulse/EWRS/IHR routes).

We thank you for all the contributions and support given so far.

If you have any questions or require further information, please do not hesitate to contact us at [email protected] (ECDC) or [email protected] (WHO Europe).

Best wishes,

ECDC and WHO EURO mpox teams

Dear colleagues,

We are writing to inform you of an extension to the monthly surveillance for mpox and the upcoming data reporting deadline to TESSy.

Kindly report the case-based mpox data to TESSy for the month of September to TESSy on or before: October 5, 2023, by 10:00 AM

We understand that this notification comes with very short notice, and we apologize for any inconvenience this may cause. We highly value your contributions and dedication to this important endeavour. We are currently working on providing more detailed information regarding submission deadlines and other related matters. We will communicate these updates to you as soon as they are available.

Please continue to report all available epidemiological and virological information related to mpox cases. Additionally, if there are any significant increases in case numbers or changes in epidemiology, such as outbreaks related to mass gathering events, re-infections among cases, or a rise in cases among women or children, we kindly request that you report these through event-based surveillance (EpiPulse). ECDC will make this information accessible to WHO Europe through the "Situation Awareness" tab in EpiPulse to avoid double-reporting to ECDC and WHO.

We want to express our gratitude to all countries that have contributed their data thus far. Your ongoing support is instrumental in our collective efforts to combat mpox.

If you have any questions or require further information, please do not hesitate to contact us at [email protected] (ECDC) or [email protected] (WHO Europe).

Thank you for your continued cooperation and dedication to mpox surveillance.

Best wishes,

ECDC and WHO EURO mpox teams

Dear colleagues,

As you will be aware, the Fifth Meeting of the International Health Regulations (2005) (IHR) Emergency Committee on the Multi-Country Outbreak of mpox (monkeypox) took place last week, please see here: https://www.who.int/news/item/11-05-2023-fifth-meeting-of-the-international-health-regulations-(2005)-(ihr)-emergency-committee-on-the-multi-country-outbreak-of-monkeypox-(mpox)

Having considered the significant decline in the global spread of mpox and the gains achieved in the control of the outbreak in many countries, the Committee advised that the event requires a transition from a PHEIC to a robust, proactive and sustainable mpox response and control program, that prevents resurgence of global spread, aims to eliminate person-to-person transmission, and mitigates the impact of local spill-over effects.

In line with this, we continue to request monthly mpox data submission to TESSy complemented by event-based surveillance with reporting through IHR mechanisms. Please report all available epidemiological and virological information.

Please continue to report case-based mpox data to TESSy for the previous month on the first Tuesday or Wednesday of each month, by 10:00AM. Due to potential overlap with holidays, the following dates for monthly data upload for the next six months are as follows:

• Wed 7 June 2023

• Wed 5 July 2023

• Wed 9 August 2023

• Wed 6 September 2023 

We will continue to publish the Joint Mpox Surveillance Bulletin on a monthly basis. Please report any significant increases in case numbers or changes in epidemiology, such as outbreaks related to mass gathering events, re-infections among cases, rise in cases among women or children, ad hoc through event-based surveillance (EpiPulse). ECDC will make the posted information accessible to WHO Europe through the “Situation Awareness” tab in EpiPulse to avoid double-reporting to ECDC and WHO.

Please also note that should there be any significant changes in mpox epidemiology in the coming months, the reporting frequency through TESSy might be changed on short notice to ensure appropriate surveillance according to the epidemiological situation.

We once again thank all countries that have contributed their data so far. Please contact [email protected] for ECDC and [email protected] for WHO Europe should you have any questions.

Best wishes,

ECDC and WHO EURO mpox teams